Thermo Fisher Scientific (TMO) PT Lowered to $665 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $706.41 +1.16%
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Baird analyst Catherine Schulte lowered the price target on Thermo Fisher Scientific (NYSE: TMO) to $665.00 (from $695.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Matador (MTDR) PT Raised to $66 at Truist Securities
- Bruker (BRKR) PT Raised to $70 at Jefferies
- Flutter Entertainment (FLUT) PT Lowered to $160 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
